Background Respiratory syncytial virus (RSV) is the most common cause of acute lower
respiratory infection in young children. We previously estimated that in 2015, 33·1 million …

Background Limited evidence is available on the real-world effectiveness of the BNT162b2
vaccine against coronavirus disease 2019 (Covid-19) and specifically against infection with …

Objectives SARS-CoV-2 infection has now a global resonance. Data on how COVID-19 is
affecting immunocompromised patients are however few. With our study we aimed to …

The data currently available on the epidemiology, severity and economic burden of nosocomial
rotavirus (RV) infections in children younger than 5 years of age in the major European …

Purpose In this proof‐of‐concept paper we describe the framework, process, and preliminary
results of combining data from European electronic healthcare record (EHR) databases for …

Background Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants.
The burden of RSV infection in healthy term infants has not yet been established. Accurate …

Objectives Previously, web-based tools for cross-sectional antimicrobial point prevalence
surveys (PPSs) have been used in adults to develop indicators of quality improvement. We …

Unlike most drugs, whose benefit is restricted to the individual who takes the drug,
prophylactic vaccines have the potential for far-reaching effects that encompass health service …

Background. Rotavirus is recognized as a significant cause of pediatric gastroenteritis
worldwide. Comprehensive data on the burden of rotavirus disease in Europe were lacking. …

Background Rotavirus (RV) is the leading cause of diarrhea-related death in children
worldwide and 95% of RV-associated deaths occur in Africa and Asia where RV vaccines (RVVs) …